Viewing Study NCT02420912

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2026-06-09 @ 10:40 AM
Study NCT ID: NCT02420912
Status: COMPLETED
Last Update Posted: 2024-03-20
First Post: 2015-04-15
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Nivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Richter Transformation
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Loss of Chromosome 17p View
None Recurrent Chronic Lymphocytic Leukemia View
None Recurrent Small Lymphocytic Lymphoma View
None Refractory Chronic Lymphocytic Leukemia View
None Refractory Small Lymphocytic Lymphoma View
None Richter Syndrome View
Keywords: